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Abstract-The product safety dilemma for over-the-counter medications involves combining safety, 
packaging, product form and consumer acceptance into a solvent bundle. The Analytic Hierarchy Process 
model is used in this study to assist in understanding the complexities and interactions of these elements 
as well as to evaluate consumer reactions to different solutions. The final outcome offers strong support 
for industries assessment of this situation, namely that product safety is a powerful overriding factor. 
INTRODUCTION 
“In food and drug packaging, tragedy has joined necessity as the mother of invention” [l]. Over 
the past decade, adulterated products have injured and killed many innocent consumers. During 
the mid-1970s adulterated milk appeared on store shelves during a large dairy strike. At another 
time, razor blades and other objects had allegedly been put into hot dogs. In 1982 and 1986, there 
were the incidents of the cyanide-laced Tylenol capsules. For this reason, many inventors have 
dedicated themselves to the problem of tamper-proof packaging. Approximately 50% of these 
inventors are consumers responding to this tragedy. “‘There’s so much craziness in the world,’ says 
Nina Perrotti Sawicki, a housewife who recently received a patent on a tamper-evident seal. ‘I just 
wanted to make something I would feel safe bringing into my home.“’ [l] 
STRUCTURE OF THE PAPER 
In this paper, we will first give a brief description of the history of tragedies associated with over- 
the-counter (OTC) medication and the industries’ reactions to these tragedies. We will be focusing 
on Johnson & Johnson, the makers of Tylenol, in particular. The majority of this paper will be 
devoted to our Analytic Hierarchy Process (AHP) model which addresses the recent problem of 
OTC medication and the consumer’s purchasing reaction to these problems. 
WHAT PHARMACEUTICAL COMPANIES ARE DOING 
After the 1982 deaths from cyanide-laced Tylenol, pharmaceutical companies were anxious to 
improve the safety of their products. But as the 1986 Tylenol deaths show, the problem has not 
been solved. After 7 people died in 1982 and yet another in 1986 from cyanide-laced Tylenol 
capsules, drug companies have invested heavily in making the outer packaging tamper-resistant; 
yet the two-piece capsules that contain the medicine have not been changed [2]. These capsules 
can easily be pulled apart, their contents emptied and replaced with poison and the capsule 
reassembled. Drug makers, however, claim that the capsules are designed to make it extremely 
difficult to empty the contents of a capsule without damaging it. They claim that a determined 
murderer would have to buy new and unused capsules of exactly the same size and colors, fill them 
with a poison and then break into a tamper-resistant bottle or package to replace the good capsules 
with poisoned ones. 
IS THERE SUCH A THING AS A TRULY TAMPER-PROOF PACKAGE? 
Most inventors have now realized that there is no such thing as a truly tamper-proof package 
[3]. The best that they can do is build alarms into the packaging, that is create better and more 
t To avoid further delay, this paper has been published without the authors’ corrections. 
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elaborate seals. At the time razor blades were put into franks, the problem was solved by putting 
metal detectors at the ends of the assembly lines. Now Mr Paul DeLeeuw, the owner of DeLeeuw 
& Hill Associates, a Detroit advertising agency, has an idea for the packaging of pharmaceutical 
products called holograms. Holograms are laser images that give an appearance of depth even 
when printed on very thin material. The holograms can only be created using very expensive 
equipment and technical expertise. Mr DeLeeuw believes a holographic seal on a bottle would 
discourage tamperers, who might be able to imitate an ordinary foil seal, and would also be odd 
enough that consumers would remember to look for it. But then again, even with holograms, an 
ingenious tamperer with the right equipment could replace a seal [l]. 
According to Tom Becze, a pharmaceutical regulation specialist, “If you’re trying to murder, and 
the person you’re trying to murder isn’t trained to detect tampering, then you’re going to be 
successful.” He feels that better packaging is only a short-term solution, while “Pharmgard” is a 
long-term one. In Mr Becze’s ideal pharmacy, OTC drugs would be sold in an area partitioned off 
from the rest of the store. In this section, locked vending devices would dispense bottled 
pharmaceuticals. “It’s not the packaging that’s a problem”, says Mr Becze, “It’s the reintroduction 
of the product to the shelf. With my idea, you would never be able to bring that unit back in and 
put it on a shelf.” 
MORE TAMPER-PROOF PACKAGING 
Another tamper-resistant package consists of a heat-shrunk band, a seal that’s slipped over 
the cap and neck of a container and then shrunk by applying heat. The containers have prongs 
on the necks so when the cap is turned, the prongs first mark and eventually pierce the band. 
“This shrink band is unique because it is an obvious visual thing and you can easily see if it’s 
twisted” [l]. Yet another invention is that of sealing wax and signet rings. If a cap and bottle are 
made of similar material and welded together, then twisting the top off would leave a jagged edge 
that could not be repaired. 
The improvement of packaging alone is not enough. Educating the consumer is also of prime 
importance. Mr Stull, owner of 15-20 patents on closures, feels “that to a certain extent consumers 
are making it easy for tamperers, they’ve become accustomed to popping things into their mouths 
without so much as a look” [ 11. Mr Deleeuw also feels that the consumer has become less cautious 
in his purchasing habits, “as time goes on people may open a bottle, find no seal and realize that 
there should be a seal there. We’re a forgiving and forgetful society”, he adds “and that’s to our 
credit and our detriment” [l]. 
JOHNSON & JOHNSON’S REACTION 
Johnson & Johnson believes that eliminating capsules and creating caplets is the only way to 
ensure the safety of the consumer and consequently, have removed all capsule products from the 
shelf. James E. Burke, chairman and chief executive officer, said “the company is leaving the capsule 
business because it cannot guarantee the safety of capsules to the degree consistent with Johnson 
& Johnson’s standards of responsibility to its consumers” [4]. 
Johnson & Johnson is hoping that the elimination of capsules and the strong campaign for 
caplets will encourage consumers to convert from capsules to caplets. Caplets are not new to the 
market and have been aggressively promoted since 1984 by the makers of Tylenol in an effort to 
move capsule users to caplets. A consumer company 3 years ago showed that 90% of capsule users 
would be willing to use caplets. Johnson & Johnson is hoping these figures will prove to be accurate 
when the capsules are removed from the market. 
The removal of capsules will cost Johnson & Johnson between $lOOm and $150m. Although the 
task seems to be costly in the short run, Johnson & Johnson is confident that in the long run the 
added safety benefits of the caplets will far outweigh the cost of removing capsules from the market. 
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STUDY OBJECTIVES 
Johnson & Johnson’s reaction to the tragic deaths due to product tampering was to replace the 
openable capsule with a solid entity called a caplet. But what is the consumer’s reaction? How do 
consumers react to the choices available to them in the OTC pain-relief marketplace? 
This study is a market analysis of the consumer’s choice behavior to OTC pain-relief medication, 
but with an emphasis on Tylenol. 
Specifically, we wanted to find out: 
1. The factors that contribute to the consumer’s choice of an OTC medication. 
2. How the consumer prioritizes (values) these factors. 
3. Given consumer choice awareness and consumer prioritization of factors, what 
alternatives would be selected. 
STUDY DESIGN 
The AHP, which enables the user to determine the relative importance of criteria sets underlying 
their choice behaviors [SJ, was selected as the appropriate model. “The crucial contribution of the 
AHP process is that it enables us to make practical decisions, based on a ‘precausal’ understanding- 
namely, on our feelings and judgments about the relative impact of one variable on another.” [6] 
HIERARCHY 
The hierarchy, shown in Fig. 1, consists of three levels. This hierarchy was constructed after a 
market analysis of consumers’ priorities. 
In this study there are four factors: price of product, safety of product, reputation of manufacturer 
and product and the method of consumption. The third level consists of five alternative product 
types available to the consumer in the market. The alternatives include: capsules, caplets, tablets, 
powder and liquid. Each element in the third level is related to the elements in the next higher 
level, the second level of the hierarchy. According to Wind and Saaty [7], “when constructing 
hierarchies one must include enough relevant detail to depict the problem as thoroughly as possible. 
Consider the environment surrounding the problem. Identify the issues or attributes that you feel 
contribute to the solution. Identify the participants associated with the problem. Arranging the 
goals, attributes, issues and stakeholders in a hierarchy serves two purposes: it provides an overall 
view of the complex relationships inherent in the situation, and it permits the decision maker to 
asses whether he is comparing issues of the same order of magnitude in weight or impact on the 
solution.” 
I I Choosing a 
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Fig. 1. The hierarchy. (Note: although not depicted in the figure, all second level factors relate to all third 
level factors). 
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assess whether he is comparing issues of the same order of magnitude in weight or impact on the 
solution.” 
After constructing the hierarchy, the next step was to establish priorities for each element in the 
hierarchy using a pairwise comparison judgment for each element against the appropriate criterion. 
A questionnaire was designed for that purpose, as suggested by Saaty [6]. 
THE QUESTIONNAIRE 
The questionnaire consists of seven pages. The first page refers to the second level of the hierarchy 
which are the factors involved in choosing a pain reliever. In order to prioritize the factors on the 
second level we asked the consumer to circle the more important factor of the pair and then circle, 
on a scale of 1-9, the number that designated how much more important the factor chosen is in 
relation to the third level of the hierarchy. The same pairwise construction was used to prioritize 
the alternatives in the first level, Each alternative in the third level was ranked in terms of 
preference in relation to each factor in the second level. For example, in terms of price the consumer 
chose which alternative he/she preferred. 
The last two pages were designed to analyze the demographics of the participants in the survey. 
The consumer was asked questions pertaining to demographics in order to classify them into 
homogeneous groups so as to draw conclusions regarding the various demographic groupings. 
DATA COLLECTION 
A sample of 350 adults where chosen from communities in northern New Jersey. The demographic 
profiles indicate a mixed background with regard to education but with an accent on youth with 
half (49%) of the sample being between 21 and 30 years of age; 56% of the respondents were female 
and 44% male. 
RESULTS 
Our study indicates that consumers have become more cautious and skeptical regarding 
packaging and content of OTC medications. Only 20% saw new packaging as very effective in 
making packages tamper-proof and 89% claimed that they were more cautious this year in their 
purchases of OTC drugs. When asked what form (liquid, caplets, capsules or tablets) they would 
prefer, only 4% preferred capsules, with about half preferring tablets and just over a third preferring 
caplets. This corroborates the previous study by Johnson & Johnson indicating that consumers 
would not object to switching from capsules to caplets, and indicates that consumers would prefer 
caplets to capsules by a 90% margin. 
THE AHP ANALYSIS 
The responses to pairwise comparison were put into matrix form for ease of assessment of the 
relative contribution of each element in one level to each element in the next higher level. 
Respondents had been asked to compare the importance of price, safety, reputation and method 
of ingestion. 
Figure 2 represents the order of importance of the four factors. The order of importance is: 
safety, reputation, method and price. Safety is seen as the dominant characteristic. Safety was rated 
highest by a strong majority and the next two factors are also basically safety considerations with price 
a weak fourth. It is to be noted that while the proportions in Fig. 2 do not imply a direct ratio 
scale (safety, at 0.52, is not twice as significant as reputation, with a rating of 0.27) the domination 
of safety needs regarding OTC medications has been clearly demonstrated. 
The third level of the hierarchy consists of the five different end-product medication forms, 
namely: capsules, caplets, tablets, liquid and powder. Respondents were asked to rank order the 
five different medication forms in terms of each of the four factors in Level 2. The preference 
orderings were identical for the criteria of price, reputation and safety (see Fig. 3): tablets, caplets, 
’ . . The AHP and the product safety dilemma 297 
Safety 
Reputation 
0.27236 
Fig. 2. Second level of the hierarchy. 
liquid, powder and capsules. The preference order for method of ingestion (see Fig. 4) is: tablets, 
caplets, liquid, capsules and powder. 
The preferences for tablets and caplets is clear as these two solid forms dominate the responses 
regardless of the criterion (Level 2 factor). 
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Fig. 3. Third level of the hierarchy 
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For the final decision the alternatives were ranked: tablets, caplets, liquid, powder and capsules. 
Again, we see in final decision the overriding importance of the safety factor with a nod towards 
convenience (Fig. 5). The total consistency of the hierarchy is 0.0082. 
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Capiets 
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Fig. 4. Method of ingestion. Fig. 5. The decision matrix 
CONCLUSIONS AND STRATEGIC IMPLICATIONS 
This study clearly points to safety as the main concern of consumers of OTC pain-relief 
medication. The 350 consumers in this study show a very strong preference for tablets and caplets 
over capsules with but 4% of the sample preferring capsules. 
The halo effect of safety cuts through other considerations so that consumers show limited 
differentiation among the four factors in Level 2 of the hierarchy, as influencers of purchase 
intention. 
The decision of Johnson & Johnson to replace capsules with caplets appears to be a good one. 
This decision reduces the risk of tampering and meets with consumer approval at the same time. 
Consumers are willing to sacrifice the capsule for the newer and safer form of medication-the 
caplet. 
This application of the AHP model has enabled us to define and solve a complex marketing 
problem. The AHP model increases the user’s understanding of problem elements and interdepend- 
ence of system elements and problem definition, while permitting the user to view a host of viable 
alternatives consistent with different goal sets. In addition to this flexibility, the AHP approach 
allows for an inexpensive analysis of a wide range of business problems. 
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